News archive for Centre for Cancer Biomarkers CCBIO

Getting started on a manuscript or scientific text can often feel like the hardest part. Wouldn't it be great to have expert guidance to kickstart the process? That’s exactly what seventy-five students and several researchers signed up for when they filled the auditorium for this year’s CCBIO908 Scientific Writing & Communication Seminar, held May 20–21, 2025.

On June 10, 2025, the Research Council of Norway announced funding for new projects in the FRIPRO scheme. Of the 3 awarded projects to the UiB, CCBIO Postdoc Harsh Dongre in Dana Costea's group received 3-year project support with international mobility.

Over two months in October–December 2024, PhD Candidate Ghazal Lessan Toussi in Carina Strell’s group at CCBIO was given the opportunity to be on a research lab stay in Dr. Watnick’s laboratory at Boston Children's Hospital in Boston, USA. This was organized in the CCBIO–VBP Lab Visit Program, which is part of the CCBIO INTPART collaboration. Ghazal returned with lots of new knowledge and... Read more

12 mill NOK was today (Dec. 20, 2024) awarded to Lars A. Akslen and Heidrun Vethe from the Research Council of Norway (FRIPRO) on the project "When breast cancer hits a nerve - neural involvement as a hallmark of tumor progression."

The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.

This year, one of CCBIO's students got the opportunity to have a 3-month research stay in Boston, due to CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Tessa Lohr reports of a great experience, highly recommending it to other young researchers.

This meeting at Solstrand August 28–31, 2024 was the 2nd Research Meeting in the INTPART collaboration between CCBIO and the Vascular Biology Program (VBP), Boston Children’s Hospital and Harvard Medical School, the first being the Iceland meeting in 2019. In 2019, 48 participants met in Iceland, and this year, 57 gathered at Solstrand.

Kari Strøno Wagner-Larsen defended November 15, 2024 her doctoral work at the University of Bergen with the thesis "Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer". Wagner-Larsen's doctoral work includes four studies showing that traditional as well as advanced, computer-assisted MRI analyses (radiomics) improve the risk assessment of patients with... Read more